Although IL-17 induces bone resorption in patients with RA, IFNγ, perhaps paradoxically, is associated with less bone erosion indicating that the development of IL-17+IFNγ+ phenotype could associate with a better outcome at least for bone loss in the disease [99]. This evidence concerns the gene IL17A and rheumatoid arthritis.